Reversair ODT 4 mg (Dispersible Tablet)
Unit Price: ৳ 7.05 (3 x 10: ৳ 211.50)
Strip Price: ৳ 70.50
Medicine Details
| Category | Details |
|---|---|
| Generic | Montelukast sodium |
| Company | Aci limited |
| Also available as |
Title and Category
- Reversair ODT 4 mg Tablet
- Medicine
Indications
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
Pharmacology
- Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1)
Dosage & Administration
- Adults and adolescents with asthma or seasonal allergic rhinitis: Montelukast 10 mg tablet once daily.
- Pediatric patients with asthma or seasonal allergic rhinitis: Montelukast 5 mg tablet once daily.
- The dosage for pediatric patients 2 years to 5 years of age: Montelukast 4 mg tablet once daily.
- The dosage for pediatric patients 6 months to 5 years of age: Montelukast 4 mg oral granules once daily.
Storage Conditions
- Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.
Chemical Structure
- Molecular Formula : C35H36ClNO3S
Therapeutic Class
- Leukotriene receptor antagonists
Side Effects
- Diarrhoea
- Fever
- Gastrointestinal discomfort
- Headache
- Nausea
- Vomiting
- Skin reactions
- Upper respiratory tract infection
- Akathisia
- Anxiety
- Arthralgia
- Asthenia
- Abnormal behavior
- Depression
- Dizziness
- Drowsiness
- Dry mouth
- Haemorrhage
- Irritability
- Malaise
- Muscle complaints
- Oedema
- Seizure
- Abnormal sensation
- Sleep disorders
- Angioedema
- Concentration impaired
- Disorientation
- Eosinophilic granulomatosis with polyangiitis
- Erythema nodosum
- Hallucination
- Hepatic disorders
- Memory loss
- Palpitations
- Pulmonary eosinophilia
- Suicidal tendencies
- Tremor
Interaction
- Reversair ODT has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions.
Contraindications
- Montelukast is contraindicated in patients who are hypersensitive to any component of this product.
Pregnancy & Lactation
- Montelukast crosses the placenta following oral dosing in rats and rabbits. There are, however, no adequate and well-controlled studies in pregnant women.
Precautions & Warnings
- Reversair ODT is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus.
Overdose Effects
- In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.
Common Questions
- What is Reversair ODT 4 mg DT?
- What is Reversair ODT 4 mg DT used for?
- How soon can the effect of Reversair ODT 4 mg DT be observed?
- How long does the effect of Reversair ODT 4 mg DT last?
- Should I use Reversair ODT 4 mg DT empty stomach?
- What if I miss a dose of Reversair ODT 4 mg DT?
- Are there any pregnancy warnings for Reversair ODT 4 mg DT?
General Instructions
- Take Reversair ODT 4 mg DT exactly as prescribed by your doctor.
- Do not change your Reversair ODT 4 mg DT dose or stop using asthma medication without your doctor's advice.
- Reversair ODT 4 mg DT is not a fast-acting rescue medicine for asthma attacks. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working.
- Avoid situations or activities that may trigger an asthma attack.
- Talk to your doctor before using Reversair ODT 4 mg DT if you're pregnant or breastfeeding. They can help you decide if it's the right choice for you.